Basiliximab

In the US, Basiliximab (basiliximab systemic) is a member of the drug class interleukin inhibitors and is used to treat Organ Transplant, Rejection Prophylaxis.

US matches:

• Basiliximab


• Basiliximab Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L04AA09,L04AC02

CAS registry number (Chemical Abstracts Service)

0179045-86-4

Chemical Formula

C6378-H9844-N1698-O1997-S48

Molecular Weight

143801

Therapeutic Category

Immunomodulator

Chemical Name

Immunoglobulin G 1 (human-mouse monoclonal CH1621 heavy chain antihuman interleukin 2 receptor), disulfide with human-mouse monoclonal CH1621 light chain, dimer

Foreign Names

• Basiliximabum (Latin)
• Basiliximab (German)
• Basiliximab (French)
• Basiliximab (Spanish)

Generic Names

• Basiliximab (OS: BAN, USAN, DCF)
• CHI 621 (IS)
• chRFT 5 (IS)
• SDZ CHI 621 (IS: Sandoz)

Brand Names

• Simulect
  Novartis, Argentina; Novartis, Australia; Novartis, Belgium; Novartis, Brazil; Novartis, Canada; Novartis, Switzerland; Novartis, Chile; Novartis, China; Novartis, Colombia; Novartis, Czech Republic; Novartis, Germany; Novartis, Denmark; Novartis, Ecuador; Novartis, Spain; Novartis, Finland; Novartis, France; Novartis, United Kingdom; Novartis, Greece; Novartis, Hong Kong; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Ireland; Novartis, Israel; Novartis, Iceland; Novartis, Italy; Novartis, Japan; Novartis, Sri Lanka; Novartis, Luxembourg; Novartis, Mexico; Novartis, Malaysia; Novartis, Netherlands; Novartis, Norway; Novartis, New Zealand; Novartis, Oman; Novartis, Philippines; Novartis, Poland; Novartis, Portugal; Novartis, Romania; Novartis, Serbia; Novartis, Russian Federation; Novartis, Sweden; Novartis, Singapore; Novartis, Slovenia; Novartis, Slovakia; Novartis, Thailand; Novartis, Tunisia; Novartis, Turkey; Novartis, Taiwan; Novartis, United States; Novartis, Venezuela; Novartis, Vietnam; Novartis, South Africa; Novartis Pharmaceuticals, Peru

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.